Q4 2024 Seer Inc Earnings Call Transcript
Key Points
- Seer Inc (SEER) reported a total revenue of $14.2 million for 2024, with a strong cash position of approximately $300 million.
- The company successfully repurchased approximately 6.5 million shares, reducing the total shares outstanding by about 10%.
- Seer Inc (SEER) expanded its global reach, serving over 135 customers across 20 countries, and doubled its commercial team in North America.
- The Proteograph Product Suite has been validated through 33 customer publications, with 23 new peer-reviewed publications in 2024.
- Seer Inc (SEER) has formed a strategic partnership with Thermo Fisher Scientific to co-market and sell the Proteograph Product Suite, enhancing commercial reach.
- Total revenue for 2024 decreased by 15% compared to 2023, primarily due to lower product sales and no grant revenue.
- The company reported a net loss of $86.6 million for the full year 2024, slightly higher than the $86.3 million loss in 2023.
- Seer Inc (SEER) experienced a 10% decrease in fourth-quarter revenue compared to the same period in 2023, due to lower instrument sales.
- There is ongoing uncertainty regarding NIH and government funding, which could impact a portion of Seer Inc (SEER)'s revenue in 2025.
- The company faces challenges with elongated sales cycles and pressure on CapEx budgets, affecting the outright purchase of new instruments.
Good day, and thank you for standing by. Welcome to the Seer fourth quarter and full year 2024 earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Carrie Mendivil, Investor Relations. Please go ahead.
Thank you. Earlier today, Seer released financial results for the quarter and year ended December 31, 2024. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected].
In addition, during today's conference call, we will be referencing a slide presentation that can be accessed on the Events and Presentations section of Seer's Investor Relations website. Joining me today from Seer is Omid Farokhzad, Chief Executive Officer and Chair of the Board; and David Horn, Chief Financial Officer and President.
Before we begin, I'd like to remind you that management
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
